New insights into aging and inflammation inhibition in atherosclerosis

Researchers are increasingly focusing on inflammation as a cause of atherosclerosis, a condition in which arteries narrow. This form of vascular calcification often leads to heart attacks and strokes in later life. In atherosclerosis, a chronic inflammatory response occurs, in which certain immune cells, called macrophag, contribute to the formation and growth of plaques in the blood vessels. Efforts to inhibit these inflammations have so far yielded limited results.

In addition to medications that lower cholesterol, new treatments are being sought that can target specific inflammatory processes. Scientists are investigating which signals and cells are involved, in the hope of finding more effective medications. It seems difficult to stop the harmful inflammatory process alone without disrupting the normal and beneficial inflammatory process.

In the field of age-related imagery, physical measurements such as grip strength are also being examined. This tool measures muscle strength and can provide an indication of biological aging. This is particularly valuable because it helps to more quickly and easily map the effects of new treatments, such as gene therapies that improve muscle or brain functions.

Furthermore, research shows that removing certain immune cell activators, such as the protein cGAS, inhibits inflammation and cell aging, but unfortunately has no effect on extending lifespan. This illustrates that the processes behind aging are complex and often require a balance between repair and defense.

These developments are important because they contribute to finding better ways to address age-related diseases earlier and more effectively, which is essential for a healthier and more active old age.

Source: Reason